Do parasympatholytic effects of long-acting β2-sympathomimetics contribute to their relaxant effects in airway smooth muscle cells?

Pulmonary Pharmacology and Therapeutics

Volumn 11, Issue 4, 1998, Pages 253-261

  Teschemacher, A ^a   Reinhardt, D ^b   Lemoine, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

3H quinuclidinyl benzilate (3H QNB); Airway smooth muscle cells; Formoterol; Long acting 2 sympathomimetics; Muscarinic acetylcholine receptors

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; DOPEXAMINE; FORMOTEROL; GUANOSINE TRIPHOSPHATE; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE; SALMETEROL; SPASMOLYTIC AGENT; TRITIUM;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG MECHANISM; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RECEPTOR AFFINITY; RECEPTOR DENSITY; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; STRUCTURE ACTIVITY RELATION; TRACHEA MUSCLE;

EID: 0032148075     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1998.0121     Document Type: Article

References (36)

1. 1. Ida H. Comparison of the action of BD 40 A (formoterol) and some other β-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig. Drug Res 1976; 26: 839-842.
2. 2. Johnson M, Butchers P R, Coleman R A, Nials A T, Strong P, Sumner M J, Vardey C J, Whelan C J. The pharmacology of salmeterol. Life Sci 1993; 52: 2131-2143.
3. 2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Respir J 1991; 4: 218-226.
4. 2-adrenoceptor agonist bronchodilator. Life Sci 1993; 52: 2145-2160.
5. 5. Johnson M. Salmeterol. Med Res Rev 1995; 15: 225-257.
6. 6. Waldeck B. Some pharmacodynamic aspects on long-acting β-adrenoceptor agonists. Gen Pharmacol 1996; 27: 575-580.
7. 2-adrenoceptor agonist, compared to salbutamol in asthmatic patients. Acta Pharmacol Toxicol 1986; 5 (Suppl. 2): 229.
8. 8. Lemoine H, Overlack C, Köhl A, Worth H, Reinhardt D. Formoterol, fenoterol, and salbutamol as partial agonists for relaxation of maximally contracted guinea pig tracheae: comparison of relaxation with receptor binding. Lung 1992; 170: 163-180.
9. 9. Lemoine H, Overlack C. Highly potent β-sympathomimetics convert to less potent partial agonists as relaxants of guinea pig trachea maximally contracted by carbachol. Comparison of relaxation with receptor binding and adenylate cyclase stimulation. J Pharmacol Exp Ther 1992; 261: 258-270.
10. 2-sympathomimetics. Comparison of relaxation with receptor binding and adenylate cyclase stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 1991; 343: R98.
11. 11. Lemoine H. β-Adrenoceptor ligands: characterization and quantification of drug effects. Quant Struct Act Relat 1992; 11: 211-218.
12. 2-sympathomimetics. Naunyn-Schmiedeberg's Arch Pharmacol 1998; 358 (Suppl. 2): R592.
13. 13. Leier C V, Unverferth D V. Drugs five years later. Dobutamine. Ann Intern Med 1983; 99: 490-496.
14. 2-adrenoceptors? J Pharmacol Exp Ther 1996; 278: 1105-1113.
15. 2-adrenoceptors. Br J Pharmacol 1985; 85: 599-608.
16. 2-adrenoceptors in guinea-pig myocardium. J Autonom Pharmacol 1990; 10: 127-137.
17. 2-Sympathomimetika Formoterol und Salmeterol eine Rolle? Monatsschr Kinderheilkd 1996; 144: 333.
18. 1-adrenoceptors: comparison with (-)-adrenaline and relation to adenylate cyclase stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 1989; 339: 85-89.
19. 19. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 1976; 72: 248-254.
20. 125I]-iodopindolol, a new highly selective radioiodinated β-adrenergic receptor antagonist: measurement of β-receptors on intact rat astrocytoma cells. J Cyclic Nucleotide Res 1980; 6: 297-307.
21. 21. Staehelin M, Simons P, Jaeggi K, Wigger N. CGP-12177. A hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 1983; 258: 3496-3502.
22. 22. Ehle B, Lemoine H, Kaumann A.J. Improved evaluation of binding of ligands to membranes containing several receptor-subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 1985; 331: 52-59.
23. 3H-ICI 118, 551 and blocking potency of ICI 118,551. Naunyn-Schmiedeberg's Arch Pharmacol 1985; 331: 40-51.
24. 24. Kerrebijn K F. Long-term drug treatment of asthma in children. Lung 1990; 168 (Suppl): 142-153.
25. 25. Haddad E B, Mak JCW, Belvisi M G, Nishikawa M, Rousell J, Barnes P J. Muscarinic and β-adrenergic receptor expression in peripheral lung from normal and asthmatic patients. Am J Physiol 1996; 270: L947-L953.
26. 26. Molfino N A, Slutsky A S, Julia-Serda G, Hoffstein V, Szalai J P, Chapman K R, Rebuck A S, Zamel N. Assessment of airway tone in asthma. Comparison between double lung transplant patients and healthy subjects. Am Rev Respir Dis 1993; 148: 1238-1243.
27. 27. Rebuck A S, Chapman K R, Abboud R, Pare P D, Kreisman H, Wolkove N, Vickerson F. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airway disease in the emergency room. Am J Med 1987; 82: 59-64.
28. 28. Eglen R M, Reddy H, Watson N, Challiss R A J. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci 1994; 15: 114-119.
29. 29. Chilvers E R, Nahorski S R. Phosphoinositide metabolism in airway smooth muscle. Am Rev Respir Dis 1990; 141: S137-S140.
30. 30. Yang C M, Chou S P, Sung T C. Muscarinic receptor subtypes coupled to generation of different second messengers in isolated tracheal smooth muscle cells. Br J Pharmacol 1991; 104: 613-618.
31. 31. Patel H J, Barnes P J, Takahashi T, Tadjkarimi S, Yacoub M H, Belvisi M G. Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea. Am J Respir Crit Care Med 1995; 152: 872-878.
32. 32. Lucchesi PA, Scheid C R, Romano F D, Kargacin M E, Mullilin-Kilpatrick D, Yamaguchi H, Honeyman T W. Ligand binding and G protein coupling of muscarinic receptors in airway smooth muscle. Am J Physiol 1990; 258: C730-C738.
33. 33. Anderson G P, Lindén A, Rabe K F. Why are long-acting β-adrenoceptor agonists long-acting? Eur Respir J 1994; 7: 569-578.
34. 34. Mitra S, Ugur M, Ugur O, Goodman H M, McCullough J R, Yamaguchi H. (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998; 53: 347-354.
35. 35. Meylan W M, Howard P H. Atom/fragment contribution method for estimating octanol-water partition coefficients. J Pharm Sci 1995; 84: 83-92.
36. 36. Ruffolo R R Jr, Spradlin T A, Pollock G D, Waddell J E, Murphy P J. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 1981; 219: 447-452.